Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
European Journal of Hospital Pharmacy : Science and Practice
|
February 18, 2020
Telmisartan-induced sprue-like enteropathy: a case report
Natalia Alzueta, Amaya Echeverría, Lorea Sanz, et al.
Antibiotics (Basel, Switzerland)
|
February 25, 2023
Impact of COVID-19 Pandemic in Antibiotic Consumption in Navarre (Spain): An Interrupted Time Series Analysis
Natalia Alzueta, Amaya Echeverría, Patricia García, et al.
Gaceta Sanitaria
|
December 24, 2022
[Off-label use of gabapentinoid drugs: is it necessary a deprescription strategy?]
Amaya Echeverría Gorriti, Natalia Alzueta Istúriz, Patricia García González, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|
June 5, 2026
Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis
Andrea Rodríguez Esquíroz, Javier Garjón Parra, Amaya Echeverría Gorriti, et al.
Stroke
|
January 2, 2010
Prevalence of embolic signals in acute coronary syndromes
Elena Meseguer, Julien Labreuche, Cloe Durdilly, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|
June 10, 2026
Pharmaceutical intervention for the reduction of risks associated with medications in patients with liver cirrhosis in primary care
Andrea Rodríguez Esquíroz, Amaya Echeverría Gorriti, Marta Marín Marín, et al.
Revista Espanola De Salud Publica
|
January 26, 2026
[Study protocol: evaluation of a pharmaceutical intervention for safe use of medications in patients with liver cirrhosis]
Andrea RodrÍguez Esquíroz, Amaya Echeverría Gorriti, Marta Marín Marín, et al.
Revista Espanola De Salud Publica
|
June 29, 2022
[Study protocol: <i>A strategy for deprescribing statins and ezetimibe in primary prevention of cardiovascular disease in patients older than 75 years: health outcomes analysis.</i>]
Natalia Alzueta Istúriz, Julen Fernández González, Amaya Echeverría Gorriti, et al.
Revista Espanola De Salud Publica
|
February 27, 2025
[Health outcomes of deprescribing proton pump inhibitors: study protocol]
Amaya Echeverría Gorriti, Andrea Rodríguez Esquiroz, Patricia García González, et al.
Pharmacoepidemiology and Drug Safety
|
March 24, 2023
Effect of the combination of diuretics, renin-angiotensin-aldosterone system inhibitors, and non-steroidal anti-inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case-control study
Dulce Maria Calvo, Luis Carlos Saiz, Leire Leache, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
European Journal of Hospital Pharmacy : Science and Practice
|
February 18, 2020
Telmisartan-induced sprue-like enteropathy: a case report
Natalia Alzueta, Amaya Echeverría, Lorea Sanz, et al.
Antibiotics (Basel, Switzerland)
|
February 25, 2023
Impact of COVID-19 Pandemic in Antibiotic Consumption in Navarre (Spain): An Interrupted Time Series Analysis
Natalia Alzueta, Amaya Echeverría, Patricia García, et al.
Gaceta Sanitaria
|
December 24, 2022
[Off-label use of gabapentinoid drugs: is it necessary a deprescription strategy?]
Amaya Echeverría Gorriti, Natalia Alzueta Istúriz, Patricia García González, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|
June 5, 2026
Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis
Andrea Rodríguez Esquíroz, Javier Garjón Parra, Amaya Echeverría Gorriti, et al.
Stroke
|
January 2, 2010
Prevalence of embolic signals in acute coronary syndromes
Elena Meseguer, Julien Labreuche, Cloe Durdilly, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria
|
June 10, 2026
Pharmaceutical intervention for the reduction of risks associated with medications in patients with liver cirrhosis in primary care
Andrea Rodríguez Esquíroz, Amaya Echeverría Gorriti, Marta Marín Marín, et al.
Revista Espanola De Salud Publica
|
January 26, 2026
[Study protocol: evaluation of a pharmaceutical intervention for safe use of medications in patients with liver cirrhosis]
Andrea RodrÍguez Esquíroz, Amaya Echeverría Gorriti, Marta Marín Marín, et al.
Revista Espanola De Salud Publica
|
June 29, 2022
[Study protocol: <i>A strategy for deprescribing statins and ezetimibe in primary prevention of cardiovascular disease in patients older than 75 years: health outcomes analysis.</i>]
Natalia Alzueta Istúriz, Julen Fernández González, Amaya Echeverría Gorriti, et al.
Revista Espanola De Salud Publica
|
February 27, 2025
[Health outcomes of deprescribing proton pump inhibitors: study protocol]
Amaya Echeverría Gorriti, Andrea Rodríguez Esquiroz, Patricia García González, et al.
Pharmacoepidemiology and Drug Safety
|
March 24, 2023
Effect of the combination of diuretics, renin-angiotensin-aldosterone system inhibitors, and non-steroidal anti-inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case-control study
Dulce Maria Calvo, Luis Carlos Saiz, Leire Leache, et al.
Page
of 2